Avadel Pharmaceuticals plc(US:AVDL) Yahoo Finance·2025-11-16 16:16Group 1 - Avadel Pharmaceuticals plc (NASDAQ:AVDL) experienced a significant stock increase of 26.06% week-on-week due to new acquisition interest from H Lundbeck A/S [1][4] - The stock reached a peak price of $23.57, the highest in over a decade, before closing at $23.56, reflecting a 22.45% increase on the day [2] - Lundbeck's acquisition offer includes a cash price of $21 per share and contingent value rights (CVR) of $2, contingent on achieving sales milestones for Lumryz and valiloxybate [3] Group 2 - Alkermes had previously proposed a lower bid of $20 per share, which Avadel's board deemed inferior to Lundbeck's offer [2][4] - Despite a definitive agreement with Alkermes, Avadel is permitted to engage in discussions with other potential buyers [5]